To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Clinical trial NCT05581199 · TERMINATED
Trial details
- NCT number
- NCT05581199
- Sponsor
- Immunovant Sciences GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2026-07-20
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.